Recent news from the China International Economic and Technical Cooperation Promotion Association: Four group standards, drafted and compiled with the lead participation of Jingjing Pharmaceutical Co., Ltd., have been officially released and implemented in August 2025. These standards are “Natural α-Ketoglutaric Acid,” “Technical Specifications for the Separation and Purification of α-Ketoglutaric Acid,” “Technical Procedures for the Microbial Fermentation Synthesis of α-Ketoglutaric Acid,” and “Safety Evaluation Methods for α-Ketoglutaric Acid Formulations.” The introduction of these standards not only fills the gaps in the domestic and international standard systems related to α-ketoglutaric acid but also marks a new phase of standardization and regulation in China’s research, development, production, and safe application of this substance, which is of great significance for promoting the high-quality development of the industry. α-Ketoglutaric acid, as an important organic acid and bioactive substance, has a wide range of applications in the fields of medicine, health products, food additives, and sports nutrition. However, for a long time, the lack of unified technical specifications and safety evaluation standards has led to inconsistent product quality on the market, hindering the healthy development of the industry. Relying on its strong technical expertise and industrialization experience, Jingjing Pharmaceutical, in collaboration with authoritative industry organizations, has taken the lead in establishing a comprehensive standard system that covers everything from raw material definition and production processes to safety evaluation. These four standards are interrelated and complement each other: - “Natural α-Ketoglutaric Acid” defines the product, classifies it, sets technical requirements, and outlines inspection methods, providing an authoritative benchmark for high-quality products. - “Technical Specifications for the Separation and Purification of α-Ketoglutaric Acid” standardizes the core production processes, ensuring high purity and yield, and serves as a guide for improving the overall industry process level. - “Technical Procedures for the Microbial Fermentation Synthesis of α-Ketoglutaric Acid” focuses on green and sustainable biomanufacturing approaches, providing a technical model for scaled and clean production in the industry. - “Safety Evaluation Methods for α-Ketoglutaric Acid Formulations” establishes a scientific and rigorous safety evaluation system to ensure the safe use of the final products. Jingjing Pharmaceutical’s successful leadership in the development of these group standards reflects its industry-leading position and technological innovation capabilities. As one of the early companies to invest in and specialize in the α-ketoglutaric acid field in China, it has built a complete industrial chain from research and development to sales. Its products are known for their high purity, stable quality, and safety, earning the trust of the market. By transforming its advanced production practices and technological achievements into industry-wide standards, Jingjing Pharmaceutical not only demonstrates its role as a pioneer but also solidifies its technical advantages as a common language and competitive benchmark in the industry, further strengthening its core competitiveness and brand authority. The release of these standards marks the end of one chapter and the beginning of a new journey. Jingjing Pharmaceutical will use the implementation of these standards as an opportunity to continue to increase investment in research and innovation, continuously improve product quality, strictly adhere to the standards, and provide customers with higher-quality, safer, and more efficient α-ketoglutaric acid products and solutions. We believe that the leadership of these standards will inject new vitality into the entire industry and promote the value of α-ketoglutaric acid in a broader range of health applications. Jingjing Pharmaceutical is willing to work with partners from all sectors to jointly promote the transformation of scientific and technological achievements, drive industry upgrading, and contribute more to the protection of human health.